Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,918.80
(
-0.14%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.14
(
0.51%
)
Bitcoin
75,763.18
(
-0.17%
)
News Focus
News Focus
Post# of 517461
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Hoskuld

Send PM Follow Ignore
Followers 35
Posts 4005
Boards Moderated 0
Alias Born 08/07/2022

Hoskuld

Re: Doc328 post# 379082

Thursday, 10/20/2022 9:29:11 AM

Thursday, October 20, 2022 9:29:11 AM

Post# of 517461
No, the trial was too small and didn't include the primary population for the indication: juveniles. Anavex is handling this perfectly. There is no reason to doubt that 2-73 will be approved for Rett after the 2nd P3 trial is analyzed and added to the eCTD.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News